• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine

Patent holdings for IPC class A61K 31/4375

Total number of patents in this class: 3306

10-year publication summary

181
248
223
295
268
270
297
302
291
96
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Novartis AG
11238
59
Deciphera Pharmaceuticals, LLC
177
54
F. Hoffmann-La Roche AG
7958
47
Bristol-myers Squibb Company
5080
43
Bayer Pharma AG
1096
42
Merck Patent GmbH
5909
41
Incyte Corporation
918
41
Boehringer Ingelheim International GmbH
4629
37
Immunomedics, Inc.
290
36
Merck Sharp & Dohme LLC
3689
33
Takeda Pharmaceutical Company Limited
2961
28
Pfizer Inc.
3322
26
Hoffmann-La Roche Inc.
3060
25
Bayer AG
3045
24
Merck Sharp & Dohme Corp.
2247
23
Gilead Sciences, Inc.
1879
23
Amgen Inc.
3779
22
Genentech, Inc.
3742
21
Mayo Foundation for Medical Education and Research
2981
21
Neurocrine Biosciences, Inc.
381
20
Other owners 2640